Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Feb. 03, 2017	Jan. 29, 2016	Jan. 30, 2015
Cash flows from operating activities:
Net earnings	$ 3,093	$ 2,546	$ 2,698
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	1,590	1,587	1,586
Deferred income taxes	28	(68)	(124)
Loss on property and other assets - net	143	30	25
Loss on cost method and equity method investments	302	594	57
Share-based payment expense	90	117	119
Changes in operating assets and liabilities:
Merchandise inventory - net	(178)	(582)	170
Other operating assets	(183)	(34)	83
Accounts payable	653	524	127
Other operating liabilities	79	70	188
Net cash provided by operating activities	5,617	4,784	4,929
Cash flows from investing activities:
Purchases of investments	(1,192)	(934)	(820)
Proceeds from sale/maturity of investments	1,254	884	805
Capital expenditures	(1,167)	(1,197)	(880)
Contributions to equity method investments - net	0	(125)	(241)
Proceeds from sale of property and other long-term assets	37	57	52
Purchases of derivative instruments	(103)	0	0
Proceeds from settlement of derivative instruments	179	0	0
Acquisition of business - net	(2,356)	0	0
Other - net	(13)	(28)	(4)
Net cash used in investing activities	(3,361)	(1,343)	(1,088)
Cash flows from financing activities:
Net change in short-term borrowings	466	43	(386)
Net proceeds from issuance of long-term debt	3,267	1,718	1,239
Repayment of long-term debt	(1,173)	(552)	(48)
Proceeds from issuance of common stock under share-based payment plans	139	125	137
Cash dividend payments	(1,121)	(957)	(822)
Repurchase of common stock	(3,595)	(3,925)	(3,905)
Other - net	(75)	55	24
Net cash used in financing activities	(2,092)	(3,493)	(3,761)
Effect of exchange rate changes on cash	(11)	(9)	(5)
Net increase/(decrease) in cash and cash equivalents	153	(61)	75
Cash and cash equivalents, beginning of year	405	466	391
Cash and cash equivalents, end of year	$ 558	$ 405	$ 466